Left ventricular assist device implantation in heart failure patients with a left ventricular thrombus

Basit Öğe Kaydı
dc.contributor.authorEngin C.
dc.contributor.authorYagdi T.
dc.contributor.authorBalcioglu O.
dc.contributor.authorErkul S.
dc.contributor.authorBaysal B.
dc.contributor.authorOguz E.
dc.contributor.authorAyik F.
dc.contributor.authorOzturk P.
dc.contributor.authorOzbaran M.
dc.date.accessioned2019-10-27T08:23:48Z
dc.date.available2019-10-27T08:23:48Z
dc.date.issued2013
dc.departmentEge Üniversitesien_US
dc.description.abstractBackground: In this report, we share our experience with left ventricular assist device (LVAD) implantation in cases with a left ventricular (LV) thrombus. Method: Over the 3 years, more than 100 end-stage heart failure cases have been treated with LVAD implantation in our center, including 6 patients with a LV thrombus. Three were detected using preoperative transthoracic echocardiography. Fifty percent of the patients had dilated cardiomyopathy and the remaining cases had an ischemic etiology. Double inotropic support with dopamine and dobutamine was used in all, with 3 drugs with the addition of adrenaline in 2 patients. In 4 cases we implanted the HeartWare Ventricular Assist System (HeartWare, Inc., Miramar, Fla, United States) and in the remaining 2 patients, the Berlin Heart EXCOR ventricular assist device (Berlin Heart AG, Berlin, Germany) for biventricular support. In 1 patient the apical ventriculotomy was extended to remove an intertrabecular thrombosis and ventricular septal surface covered with a dacron patch to minimize the thrombogenic potential. Results: Two patients died due to sepsis and multiorgan failure. None of the patients experienced a neurological event, pump thrombosis, or pump malfunction. Two subjects underwent re-explorations due to hemorrhage. Two candidates underwent successfull transplantation without any evidence of thrombosis in the explanted heart or device. Conclusion: We believe that patients with a LV thrombus and preserved right ventricular function are good candidates for implantation of a LVAD after removing the intracavitary thrombus. © 2013 Elsevier Inc.en_US
dc.identifier.doi10.1016/j.transproceed.2013.02.071en_US
dc.identifier.endpage1019en_US
dc.identifier.issn0041-1345
dc.identifier.issue3en_US
dc.identifier.pmid23622612en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage1017en_US
dc.identifier.urihttps://doi.org/10.1016/j.transproceed.2013.02.071
dc.identifier.urihttps://hdl.handle.net/11454/26485
dc.identifier.volume45en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.relation.ispartofTransplantation Proceedingsen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleLeft ventricular assist device implantation in heart failure patients with a left ventricular thrombusen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu